A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: LY573636-sodium
Sponsor: Eli Lilly and Company